{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:14:28Z","timestamp":1778786068712,"version":"3.51.4"},"reference-count":90,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background and aim:<\/jats:title>\n            <jats:p>Modulating the gut microbiota population by administration of probiotics, prebiotics, and synbiotics has shown to have a variety of health benefits in different populations, particularly those with metabolic disorders. Although the promising effects of these compounds have been observed in the management of patients with non-alcoholic fatty liver disease (NAFLD), the exact effects and the mechanisms of action are yet to be understood. In the present study, we aimed to evaluate how gut microbiota modulation affects anthropometric indices of NAFLD patients to achieve a comprehensive summary of current evidence-based knowledge.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Two researchers independently searched international databases, including PubMed, Scopus, and Web of Science, from inception to June 2023. Meta-analysis studies that evaluated the effects of probiotics, prebiotics, and synbiotics on patients with NAFLD were entered into our umbrella review. The data regarding anthropometric indices, including body mass index, weight, waist circumference (WC), and waist-to-hip ratio (WHR), were extracted by the investigators. The authors used random effect model for conducting the meta-analysis. Subgroup analysis and sensitivity analysis were also performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total number of 13 studies were finally included in our study. Based on the final results, BMI was significantly decreased in NAFLD patients by modulation of gut microbiota [effect size (ES): \u22120.18, 05% CI: \u22120.25, \u22120.11, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001]; however, no significant alteration was observed in weight and WC (ES: \u22121.72, 05% CI: \u22123.48, 0.03, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.055, and ES: \u22120.24, 05% CI: \u22120.75, 0.26, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.353, respectively). The results of subgroup analysis showed probiotics had the most substantial effect on decreasing BMI (ES: \u22120.77, 95% CI: \u22121.16, \u22120.38, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001) followed by prebiotics (ES: \u22120.51, 95% CI: \u22120.76, \u22120.27, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001) and synbiotics (ES: -0.12, 95% CI: \u22120.20, \u22120.04, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>In conclusion, the present umbrella meta-analysis showed that although modulation of gut microbiota by administration of probiotics, prebiotics, and synbiotics had promising effects on BMI, no significant change was observed in the WC and weight of the patients. No sufficient data were available for other anthropometric indices including waist-to-hip ratio and waist-to-height ratio and future meta-analyses should be done in this regard.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000001740","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T02:01:56Z","timestamp":1706061716000},"page":"2900-2910","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Can modulation of gut microbiota affect anthropometric indices in patients with non-alcoholic fatty liver disease? An umbrella meta-analysis of randomized controlled trials"],"prefix":"10.1097","volume":"86","author":[{"given":"Ehsan","family":"Amini-Salehi","sequence":"first","affiliation":[{"name":"Gastrointestinal and Liver Diseases Research Center"},{"name":"Student Research Committee, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran"},{"name":"Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Samethadka Nayak","sequence":"additional","affiliation":[{"name":"Yale New Haven Health Bridgeport Hospital, Bridgeport CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautam","family":"Maddineni","sequence":"additional","affiliation":[{"name":"Florida State University, Tallahassee, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abinash","family":"Mahapatro","sequence":"additional","affiliation":[{"name":"Hi-Tech Medical College and Hospital, Rourkela, Odisha, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad-Hossein","family":"Keivanlou","sequence":"additional","affiliation":[{"name":"Gastrointestinal and Liver Diseases Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saman","family":"Soltani Moghadam","sequence":"additional","affiliation":[{"name":"School of Medicine, Guilan University of Medical Sciences, Rasht"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azin","family":"Vakilpour","sequence":"additional","affiliation":[{"name":"School of Medicine, Guilan University of Medical Sciences, Rasht"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam Sadat","family":"Aleali","sequence":"additional","affiliation":[{"name":"Gastrointestinal and Liver Diseases Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farahnaz","family":"Joukar","sequence":"additional","affiliation":[{"name":"Gastrointestinal and Liver Diseases Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Hashemi","sequence":"additional","affiliation":[{"name":"Student Research Committee, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naeim","family":"Norouzi","sequence":"additional","affiliation":[{"name":"Gastrointestinal and Liver Diseases Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Bakhshi","sequence":"additional","affiliation":[{"name":"Gastrointestinal and Liver Diseases Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Bahrampourian","sequence":"additional","affiliation":[{"name":"Gastrointestinal and Liver Diseases Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariborz","family":"Mansour-Ghanaei","sequence":"additional","affiliation":[{"name":"Gastrointestinal and Liver Diseases Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soheil","family":"Hassanipour","sequence":"additional","affiliation":[{"name":"Gastrointestinal and Liver Diseases Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,5]]},"reference":[{"key":"R1-20250806","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R2-20250806","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7861\/clinmedicine.18-3-245","article-title":"Non-alcoholic fatty liver disease","volume":"18","author":"Maurice","year":"2018","journal-title":"Clin Med (Lond)"},{"key":"R3-20250806","first-page":"76","article-title":"Non-alcoholic fatty liver disease: growing burden, adverse outcomes and associations","volume":"8","author":"Kumar","year":"2020","journal-title":"J Clin Transl Hepatol"},{"key":"R4-20250806","first-page":"1600","article-title":"The prevalence of non-alcoholic fatty liver disease in iranian children and adult population: a systematic review and meta-analysis","volume":"52","author":"Hassanipour","year":"2023","journal-title":"Iran J Public Health"},{"key":"R5-20250806","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.3390\/nu11112837","article-title":"Role of probiotics in non-alcoholic fatty liver disease: does gut microbiota matter?","volume":"11","author":"Xie","year":"2019","journal-title":"Nutrients"},{"key":"R6-20250806","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41575-019-0239-2","article-title":"What\u2019s new in NAFLD pathogenesis, biomarkers and treatment?","volume":"17","author":"Byrne","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R7-20250806","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.clinthera.2021.01.021","article-title":"Therapy for nonalcoholic fatty liver disease: current options and future directions","volume":"43","author":"Campbell","year":"2021","journal-title":"Clin Ther"},{"key":"R8-20250806","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/apt.15314","article-title":"Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications","volume":"50","author":"Jayakumar","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"R9-20250806","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"R10-20250806","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"R11-20250806","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"R12-20250806","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis Model Mech"},{"key":"R13-20250806","first-page":"896","article-title":"Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview","volume":"118","author":"Amih\u0103esei","year":"2014","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"R14-20250806","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1210\/jc.2015-3444","article-title":"Body mass index and risk of nonalcoholic fatty liver disease: two electronic health record prospective studies","volume":"101","author":"Loomis","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-20250806","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jceh.2017.05.005","article-title":"Simple anthropometric indices are useful for predicting non-alcoholic fatty liver disease [NAFLD] in Asian Indians","volume":"7","author":"Singh","year":"2017","journal-title":"J Clin Exp Hepatol"},{"key":"R16-20250806","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12876-018-0840-9","article-title":"Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults","volume":"18","author":"K\u00fchn","year":"2018","journal-title":"BMC Gastroenterology"},{"key":"R17-20250806","doi-asserted-by":"crossref","first-page":"e131523","DOI":"10.5812\/hepatmon-131523","article-title":"Risk factors of non-alcoholic fatty liver disease in the Iranian adult population: a systematic review and meta-analysis","volume":"23","author":"Amini-Salehi","year":"2023","journal-title":"Hepatitis Monthly"},{"key":"R18-20250806","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3390\/nu12051316","article-title":"Beyond body weight-loss: dietary strategies targeting intrahepatic fat in NAFLD","volume":"12","author":"Worm","year":"2020","journal-title":"Nutrients"},{"key":"R19-20250806","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-G\u00f3mez","year":"2017","journal-title":"J Hepatol"},{"key":"R20-20250806","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"R21-20250806","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"R22-20250806","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jhep.2011.06.010","article-title":"Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review","volume":"56","author":"Thoma","year":"2012","journal-title":"J Hepatol"},{"key":"R23-20250806","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R24-20250806","doi-asserted-by":"crossref","first-page":"81","DOI":"10.12938\/bmfh.18-032","article-title":"The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms","volume":"38","author":"Jasirwan","year":"2019","journal-title":"Biosci Microbiota Food Health"},{"key":"R25-20250806","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.clnesp.2023.07.087","article-title":"Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: an umbrella study on meta-analyses","volume":"57","author":"Mahapatro","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"R26-20250806","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.3390\/nu11112642","article-title":"The role of probiotics in nonalcoholic fatty liver disease: a new insight into therapeutic strategies","volume":"11","author":"Meroni","year":"2019","journal-title":"Nutrients"},{"key":"R27-20250806","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3390\/foods10081719","article-title":"Probiotics and prebiotics as a strategy for non-alcoholic fatty liver disease, a narrative review","volume":"10","author":"Castillo","year":"2021","journal-title":"Foods"},{"key":"R28-20250806","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1007\/s13197-015-1921-1","article-title":"Probiotics, prebiotics and synbiotics\u2014a review","volume":"52","author":"Pandey","year":"2015","journal-title":"J Food Sci Technol"},{"key":"R29-20250806","doi-asserted-by":"crossref","first-page":"e017995","DOI":"10.1136\/bmjopen-2017-017995","article-title":"Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials","volume":"9","author":"Koutnikova","year":"2019","journal-title":"BMJ Open"},{"key":"R30-20250806","doi-asserted-by":"crossref","first-page":"8805","DOI":"10.3390\/ijms23158805","article-title":"The effects of probiotics, prebiotics and synbiotics in non-alcoholic fat liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a systematic review","volume":"23","author":"Carpi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R31-20250806","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2174\/1389201023666220818145350","article-title":"Prebiotics and probiotics: effects on dyslipidemia and NAFLD\/NASH and the associated mechanisms of action","volume":"24","author":"Rodr\u00edguez-Past\u00e9n","year":"2023","journal-title":"Curr Pharm Biotechnol"},{"key":"R32-20250806","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.3390\/nu12113460","article-title":"The relationship between prebiotic supplementation and anthropometric and biochemical parameters in patients with NAFLD\u2014a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Stachowska","year":"2020","journal-title":"Nutrients"},{"key":"R33-20250806","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.3390\/cells11182827","article-title":"Age-related NAFLD: the use of probiotics as a supportive therapeutic intervention","volume":"11","author":"Campagnoli","year":"2022","journal-title":"Cells"},{"key":"R34-20250806","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13643-023-02299-x","article-title":"Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study","volume":"12","author":"Naghipour","year":"2023","journal-title":"Syst Rev"},{"key":"R35-20250806","first-page":"nuad086","article-title":"The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis","author":"Amini-Salehi","year":"2023","journal-title":"Nutr Rev"},{"key":"R36-20250806","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/obr.12626","article-title":"Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: a systematic review and meta\u2010analysis of randomized controlled trials","volume":"19","author":"Borgeraas","year":"2018","journal-title":"Obes Rev"},{"key":"R37-20250806","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/ijms17060928","article-title":"Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: a review of human clinical trials","volume":"17","author":"S\u00e1ez-Lara","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R38-20250806","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.3748\/wjg.v19.i40.6911","article-title":"Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis","volume":"19","author":"Ma","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R39-20250806","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1007\/s10620-019-05699-z","article-title":"Efficacy of probiotics and synbiotics in patients with nonalcoholic fatty liver disease: a meta-analysis","volume":"64","author":"Liu","year":"2019","journal-title":"Dig Dis Sci"},{"key":"R40-20250806","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/nutrit\/nuy031","article-title":"Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"76","author":"Loman","year":"2018","journal-title":"Nutr Rev"},{"key":"R41-20250806","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/MPG.0000000000003537","article-title":"The benefit of probiotics in pediatric nonalcoholic fatty liver disease: a meta-analysis of randomized control trials","volume":"75","author":"Gkiourtzis","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R42-20250806","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1080\/10408398.2018.1458021","article-title":"Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD","volume":"59","author":"Hadi","year":"2019","journal-title":"Crit Rev Food Sci Nutr"},{"key":"R43-20250806","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"R44-20250806","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"R45-20250806","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"R46-20250806","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R47-20250806","first-page":"7888076","article-title":"Effect of probiotics therapy on nonalcoholic fatty liver disease","volume":"2022","author":"Huang","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"R48-20250806","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5005\/jp-journals-10018-1233","article-title":"Role of probiotics in the treatment of nonalcoholic fatty liver disease: a meta-analysis","volume":"7","author":"Lavekar","year":"2017","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"R49-20250806","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/ajcn\/nqz042","article-title":"Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression","volume":"110","author":"Sharpton","year":"2019","journal-title":"Am J Clin Nutr"},{"key":"R50-20250806","doi-asserted-by":"crossref","first-page":"1756284819878046","DOI":"10.1177\/1756284819878046","article-title":"Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"12","author":"Tang","year":"2019","journal-title":"Therap Adv Gastroenterol"},{"key":"R51-20250806","first-page":"1484598","article-title":"Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease, Gastroenterol Res Pract 2019","author":"Xiao"},{"key":"R52-20250806","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1080\/17474124.2022.2016391","article-title":"Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"15","author":"Yang","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R53-20250806","doi-asserted-by":"crossref","first-page":"9935","DOI":"10.3390\/ijerph19169935","article-title":"Historical changes in weight classes and the influence of nafld prevalence: a population analysis of 34,486 individuals","volume":"19","author":"Nah","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"suppl 2","key":"R54-20250806","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.14521","article-title":"A clinical overview of non-alcoholic fatty liver disease: a guide to diagnosis, the clinical features, and complications\u2014what the non-specialist needs to know","volume":"24","author":"Muthiah","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"R55-20250806","first-page":"271","article-title":"Influence of the microbiota and probiotics in obesity","volume":"30","author":"Fontan\u00e9","year":"2018","journal-title":"Clin Investig Arterioscler"},{"key":"R56-20250806","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/4441022a","article-title":"Microbial ecology: human gut microbes associated with obesity","volume":"444","author":"Ley","year":"2006","journal-title":"Nature"},{"key":"R57-20250806","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1073\/pnas.0812600106","article-title":"Human gut microbiota in obesity and after gastric bypass","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R58-20250806","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2217\/fmb.15.13","article-title":"Systematic review on intervention with prebiotics\/probiotics in patients with obesity-related nonalcoholic fatty liver disease","volume":"10","author":"Tarantino","year":"2015","journal-title":"Future Microbiol"},{"key":"R59-20250806","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4158\/EP151157.RA","article-title":"Gut microbiota, prebiotics, probiotics, and synbiotics in management of obesity and prediabetes: review of randomized controlled trials","volume":"22","author":"Barengolts","year":"2016","journal-title":"Endocr Pract"},{"key":"R60-20250806","doi-asserted-by":"crossref","first-page":"e54617","DOI":"10.1371\/journal.pone.0054617","article-title":"Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice","volume":"8","author":"Kang","year":"2013","journal-title":"PLoS One"},{"key":"R61-20250806","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/cei.12474","article-title":"Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota","volume":"179","author":"Peterson","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"R62-20250806","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1472-6882-14-247","article-title":"Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity","volume":"14","author":"Savcheniuk","year":"2014","journal-title":"BMC Complement Altern Med"},{"key":"R63-20250806","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3920\/BM2014.0014","article-title":"Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice","volume":"5","author":"Stenman","year":"2014","journal-title":"Benef Microbes"},{"key":"R64-20250806","doi-asserted-by":"crossref","first-page":"16731","DOI":"10.1073\/pnas.0804812105","article-title":"Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients","volume":"105","author":"Sokol","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R65-20250806","doi-asserted-by":"crossref","first-page":"33586","DOI":"10.1074\/jbc.M405817200","article-title":"Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis","volume":"279","author":"Davis","year":"2004","journal-title":"J Biol Chem"},{"key":"R66-20250806","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2217\/clp.12.40","article-title":"Research advances with regards to clinical outcome and potential mechanisms of the cholesterol-lowering effects of probiotics","volume":"7","author":"Zhuang","year":"2012","journal-title":"Clin Lipidol"},{"key":"R67-20250806","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/ajcn\/61.6.1241","article-title":"Propionate inhibits incorporation of colonic [1,2-13C]acetate into plasma lipids in humans","volume":"61","author":"Wolever","year":"1995","journal-title":"Am J Clin Nutr"},{"key":"R68-20250806","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1007\/s00125-007-0791-0","article-title":"Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia","volume":"50","author":"Cani","year":"2007","journal-title":"Diabetologia"},{"key":"R70-20250806","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/nu8070397","article-title":"Beneficial effect of synbiotic supplementation on hepatic steatosis and anthropometric parameters, but not on gut permeability in a population with nonalcoholic steatohepatitis","volume":"8","author":"Ferolla","year":"2016","journal-title":"Nutrients"},{"key":"R71-20250806","first-page":"1031","article-title":"Pro- and prebiotic effects on oxidative stress and inflammatory markers in non-alcoholic fatty liver disease","volume":"27","author":"Javadi","year":"2018","journal-title":"Asia Pac J Clin Nutr"},{"key":"R72-20250806","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/1751-2980.12561","article-title":"Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: a pilot trial","volume":"18","author":"Manzhalii","year":"2017","journal-title":"J Dig Dis"},{"key":"R73-20250806","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00394-018-1721-2","article-title":"Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial","volume":"58","author":"Bomhof","year":"2019","journal-title":"Eur J Nutr"},{"key":"R74-20250806","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature11552","article-title":"Functional interactions between the gut microbiota and host metabolism","volume":"489","author":"Tremaroli","year":"2012","journal-title":"Nature"},{"key":"R75-20250806","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1017\/jns.2019.36","article-title":"Is reduction in appetite beneficial for body weight management in the context of overweight and obesity? Yes, according to the SATIN (Satiety Innovation) study","volume":"8","author":"Hansen","year":"2019","journal-title":"J Nutr Sci"},{"key":"R76-20250806","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.3390\/microorganisms8081148","article-title":"Probiotics for the treatment of overweight and obesity in humans\u2014a review of clinical trials","volume":"8","author":"Wici\u0144ski","year":"2020","journal-title":"Microorganisms"},{"key":"R77-20250806","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1194\/jlr.R036012","article-title":"The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism","volume":"54","author":"den Besten","year":"2013","journal-title":"J Lipid Res"},{"key":"R78-20250806","doi-asserted-by":"crossref","first-page":"150","DOI":"10.15171\/mejdd.2017.66","article-title":"Effects of probiotic and prebiotic supplementation on leptin, adiponectin, and glycemic parameters in non-alcoholic fatty liver disease: a randomized clinical trial","volume":"9","author":"Behrouz","year":"2017","journal-title":"Middle East J Dig Dis"},{"key":"R79-20250806","first-page":"1278","article-title":"Inhibition of Escherichia coli O157: H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells","volume":"18","author":"Kim","year":"2008","journal-title":"J Microbiol Biotechnol"},{"key":"R80-20250806","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00383-002-0855-7","article-title":"Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model","volume":"18","author":"Mattar","year":"2002","journal-title":"Pediatr Surg Int"},{"key":"R81-20250806","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/gut.52.6.827","article-title":"Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro","volume":"52","author":"Mack","year":"2003","journal-title":"Gut"},{"key":"R82-20250806","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/gut.52.7.988","article-title":"Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC)","volume":"52","author":"Resta-Lenert","year":"2003","journal-title":"Gut"},{"key":"R83-20250806","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1080\/14767058.2017.1310193","article-title":"The effects of probiotic supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes","volume":"31","author":"Badehnoosh","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R84-20250806","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/path.2286","article-title":"Innate and adaptive mechanisms to control [corrected] pathological intestinal inflammation","volume":"214","author":"Kelsall","year":"2008","journal-title":"J Pathol"},{"key":"R85-20250806","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.coi.2007.06.008","article-title":"Defensins in the immunology of bacterial infections","volume":"19","author":"Menendez","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"R86-20250806","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1126\/science.1093131","article-title":"Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption","volume":"303","author":"Altmann","year":"2004","journal-title":"Science"},{"key":"R87-20250806","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.3168\/jds.2012-6371","article-title":"Characterization of Lactobacillus plantarum Lp27 isolated from Tibetan kefir grains: a potential probiotic bacterium with cholesterol-lowering effects","volume":"96","author":"Huang","year":"2013","journal-title":"J Dairy Sci"},{"key":"R88-20250806","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1017\/S0007114509991991","article-title":"The probiotic Lactobacillus acidophilus reduces cholesterol absorption through the down-regulation of Niemann-Pick C1-like 1 in Caco-2 cells","volume":"103","author":"Huang","year":"2010","journal-title":"Br J Nutr"},{"key":"R89-20250806","first-page":"3862971","article-title":"The potential role of probiotics in controlling overweight\/obesity and associated metabolic parameters in adults: a systematic review and meta-analysis","volume":"2019","author":"Wang","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"key":"R90-20250806","doi-asserted-by":"crossref","first-page":"e0178868","DOI":"10.1371\/journal.pone.0178868","article-title":"Effect of probiotic Lactobacillus on lipid profile: a systematic review and meta-analysis of randomized, controlled trials","volume":"12","author":"Wu","year":"2017","journal-title":"PLoS One"},{"key":"R91-20250806","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jnutbio.2014.10.016","article-title":"Enhanced AMPK phosphorylation contributes to the beneficial effects of Lactobacillus rhamnosus GG supernatant on chronic-alcohol-induced fatty liver disease","volume":"26","author":"Zhang","year":"2015","journal-title":"J Nutr Biochem"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000001740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:24:03Z","timestamp":1754486643000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000001740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":90,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000001740","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]},"assertion":[{"value":"2023-09-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}